Key Insights

Highlights

Success Rate

89% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

6.0%

3 terminated out of 50 trials

Success Rate

89.3%

+2.8% vs benchmark

Late-Stage Pipeline

18%

9 trials in Phase 3/4

Results Transparency

16%

4 of 25 completed with results

Key Signals

4 with results89% success

Data Visualizations

Phase Distribution

38Total
Not Applicable (27)
P 2 (2)
P 3 (2)
P 4 (7)

Trial Status

Completed25
Unknown12
Recruiting4
Terminated3
Active Not Recruiting3
Enrolling By Invitation2

Trial Success Rate

89.3%

Benchmark: 86.5%

Based on 25 completed trials

Clinical Trials (50)

Showing 20 of 20 trials
NCT03538210CompletedPrimary

Obesity Cohort Bichat Louis Mourier

NCT06162715Phase 2Enrolling By InvitationPrimary

GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Pilot Trial

NCT04915014Not ApplicableActive Not RecruitingPrimary

Sleeve Gastrectomy With Transit Bipartition(SG+TB) Versus Roux-en-Y Gastric Bypass (RYGB) for Type 3 Obesity

NCT07058155Phase 4Recruiting

Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease

NCT07280845CompletedPrimary

Longitudinal Retrospective Analysis of Prospectively Collected Data for Outcomes After Primary Sleeve Gastrectomy (N=20 000) in the Swedish National Quality Registry SOReg (Scandinavian Obesity Surgery Registry)

NCT04626232Not ApplicableTerminatedPrimary

Comparison of the Sleeve Gastrectomy Technique With a Nissen Fundoplication Added to the Conventional Sleeve Gastrectomy Technique in Morbidly Obese Patients

NCT07158008Not ApplicableRecruiting

Comparison of Nissen-Sleeve and Gastric Bypass for GERD in Obese Patients

NCT07135141Not ApplicableNot Yet RecruitingPrimary

Mazdutide as Adjuvant Therapy Following Sleeve Gastrectomy in Severe Obesity

NCT06547515Recruiting

Bone and Muscle Health Following Sleeve Gastrectomy in Men, Premenopausal and Postmenopausal Women

NCT04165694Not ApplicableActive Not Recruiting

Single Anastomosis Duodenal Ileal Bypass (SADI) for Sleeve Revision

NCT02128802Not ApplicableCompletedPrimary

Obesity Surgery and Kidney Transplant for Patients With Obesity and Renal Failure

NCT06757296Not ApplicableRecruiting

Endoscopic Conversion of Sleeve Gastrectomy to Single Anastomosis Sleeve-ileal Bypass (SASI) for Gastroesophageal Reflux (GERD), Primary and Secondary Non-responder.

NCT05832190Not ApplicableTerminatedPrimary

Correcting GUT MicrobioTa by Combined Supplementation of FibERs and BIotiN to Improve Microbiome and Optimize Bariatric Surgery Outcomes

NCT05409612Phase 3Completed

Trial Assessing the Immunogenicity and Safety of Two Influenza Vaccine Strategies Among Severe Obese Adult Patients

NCT02767505Not ApplicableActive Not RecruitingPrimary

Bypass Equipoise Sleeve Trial (BEST)

NCT04741074Phase 3Terminated

Effect of Subcutaneous Semaglutide on Kidney Transplant Candidacy

NCT02710786UnknownPrimary

Comorbidity After Gastric Bypass

NCT06162416UnknownPrimary

Non-opioid Anesthesia in Bariatric Surgery

NCT06043245Not ApplicableEnrolling By InvitationPrimary

Diabetes Remission and Hypoabsorptive Bariatric Surgery

NCT03638895Not ApplicableCompleted

Energy Expenditure From ECAL Indirect Calorimeter in a Multicomponent Weight Management Service

Scroll to load more

Research Network

Activity Timeline